Heparin-induced thrombocytopenia (HIT) is characterized clinically by thrombocytopenia,
hypercoagulability, and increased thrombosis risk, and serologically by platelet-activating …

A striking feature of COVID-19 is the high frequency of thrombosis, particularly in patients
who require admission to intensive care unit because of respiratory complications …

The immune response in heparin-induced thrombocytopenia (HIT) is puzzling: heparin-
naive patients can develop IgG antibodies and clinical HIT as early as day 5, and evidence …

Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating antiplatelet factor
4/heparin antibodies. However, clinical HIT (thrombocytopenia or thrombosis, or both) …

BACKGROUND: Diagnosing postoperative heparin-induced thrombocytopenia (HIT) in
cardiothoracic surgical patients is complicated because of the profound thrombocytopenia …

Platelet-activating antibodies, which recognize platelet factor 4 (PF4)/heparin complexes,
induce spontaneous heparin-induced thrombocytopenia (HIT) syndrome or fondaparinux …

Heparin‐induced thrombocytopenia (HIT) is a serious drug reaction that leads to a decrease
in platelet count and a high risk of thrombosis. HIT patients produce pathogenic …

Background Heparin-induced thrombocytopenia (HIT) is an immune-mediated reaction to
heparin that provokes a prothrombotic state and causes a decline in platelet count. Data …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a viral respiratory
illness initially described in Wuhan, China, and was declared a pandemic by World Health …

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is caused by anti–platelet factor
4/heparin (PF4/H) immunoglobulin (Ig) G antibodies, which activate platelets. In some …